Randomized Clinical Trial of Intermittent Calorie Restriction in People with Multiple Sclerosis: Effects on Immunometabolic and Cognitive Measures
نویسندگان
چکیده
Abstract BACKGROUND: Intermittent calorie restriction (iCR) reduces inflammation in preclinical models and people with Multiple Sclerosis (pwMS). Mechanisms could be related to changes levels of adipose tissue-derived adipokines reduced systemic gut microbiota composition. AIMS: Evaluate the effects iCR on levels, metabolic immune/inflammatory biomarkers compared a control unrestricted diet (Ctr) pwMS. METHODS: PwMS (relapsing Remitting MS) were randomly assigned or Ctr groups for 12 weeks. Blood was collected at baseline, 6 Leptin adiponectin peripheral blood immunologic profiling, anthropometric total body fat measures, clinical cognitive measures evaluated. Differences between examined using linear, repeated mixed model adjusted baseline age, sex DMTs. RESULTS: 42 pwMS randomized (iCR=22 Ctr=20). 34 completed study (iCR=17 Ctr=17). showed significant reduction (weight BMI) adiposity (waist circumference mass) over decreased significantly lower group weeks approaching significance Adiponectin increased from The decrease Th1 cells an increase CD45RO+ regulatory T after Cognitive testing symbol digit modality test greater improvement versus CONCLUSIONS: Short term is safe feasible pwMS, it can ameliorate metabolic, immunologic, profiles. National Society # RG-1607-25158
منابع مشابه
The Effectiveness of Cognitive-Behavioral Therapy in Pain Self-Efficacy, Fatigue, Life Expectancy and Depression in Patients with Multiple Sclerosis (MS): A Randomized Controlled Clinical Trial
Objective: The present study was conducted to investigate the effectiveness of cognitive-behavioral therapy in pain self-efficacy, fatigue, life expectancy and depression in patients with multiple sclerosis (MS). Methods: In a semi-experimental research with a control group pretest-posttest design, 68 patients with multiple sclerosis (MS) were selected through convenience sampling from neurolo...
متن کاملP 151: Clinical Trial in Cell Therapy of Multiple Sclerosis
Neuroinflammation is a disorder that causes neurological disease. Neuroinflammation has a significant role in induce of Multiple sclerosis (MS) and one of the situations that must be treated stops the ongoing process of inflammation against the CNS by self-reactive lymphocytes. According to the successful results that were obtained from the pre-clinical phase of cell therapy, many studies were ...
متن کاملFingolimod versus High Dose Interferon Beta-1a in Multiple Sclerosis: A Randomized Clinical Trial
Background: High dose Interferon Beta and Fingolimod are efficient in Multiple Sclerosis. Objectives: Comparison the efficacy of these two drugs in patients with treatment failure on low dose interferon beta. Materials and Methods: The MS patients (McDonald criteria 2010) with the history of unbeneficial treatment on low dose interferon beta participated in this randomized clinical trial ...
متن کاملMaternal Side-Effects of Continuous vs. Intermittent Method of Entonox During Labor: A Randomized Clinical Trial
Labor pain is one of the most tiresome types of pain. So human has been seeking to allay this pain until now. Administration of a suitable agent such as Entonox during labor is very beneficial for childbirth outcomes. Entonox can be administered in two ways: intermittently and continuously. The aim of this study is to demonstrate whether continuous method is as safe as intermittent method? This...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Immunology
سال: 2023
ISSN: ['1550-6606', '0022-1767']
DOI: https://doi.org/10.4049/jimmunol.210.supp.165.05